This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The following is a guest article by Bill Young, Director of Healthcare & LifeSciences at SYSTRAN Keeping patient data confidential and secure remains a major healthcare challenge today, more than 25 years after the introduction of the 1996 Health Insurance Portability & Accountability Act or HIPAA.
Today, we are going to focus on emerging technologies in regard to healthinformation management. We reached out to our talented Healthcare IT Today Community and asked them how can healthinformation management professionals leverage emerging technologies, such as AI , to enhance data integrity and streamline processes?
– Microsoft has announced advancements in cloud technologies for healthcare and lifesciences with the general availability of Azure Health Data Services and updates to Microsoft Cloud for Healthcare. Microsoft took a step to address health data interoperability with Azure API for FHIR in 2019. ORLANDO, Fla.
The poll results are published in Public Perspectives on Personalized Medicine , with the top-line finding that lifescience industry innovators must better educate and inform consumers on the opportunities and benefits of personalized medicine. This picture of U.S.
For example, in the healthcare industry, we have to abide by HIPAA — a law that helps protect the privacy and security of people’s healthinformation. We can’t serve our patients if we don’t ensure that protected healthinformation (PHI) is kept private.
Pratik Maroo, Head of Healthcare and LifeSciences at Zensar It is estimated that the value of medical IoT devices will be $467.25 That said, wearables contain and transmit significant amounts of protected valuable healthinformation. billion by 2027.
The following is a guest article by Ben Cushing, Chief Architect of Health and LifeSciences at Red Hat Artificial intelligence (AI) is showing up in more healthcare contexts, from drug discovery to diagnostic imaging to robot-assisted surgery. AI can then translate the clinical concepts into standard formats.
It is critical to understand the threats to the organization, the business functions, and the information systems that store, process, and transmit protected healthinformation. Pratik Maroo, Head of Healthcare and LifeSciences at Zensar The first step is to assess its vulnerabilities and strengths.
Embedded in Apple’s Health app, the new feature will bring together medical data from participating hospitals and clinics, as well as from the iPhone itself, giving millions of Americans direct digital control of their own healthinformation for the first time. Verily Verily, formerly Google LifeSciences, was founded in 2015.
My background throughout my entire professional services career, outside of running the global analytics business, was healthcare — lifesciences, domestic government work, international healthcare work, providers in health insurance. We are very pro consumers getting their healthinformation.
Both HIPAA and related state laws create strict guidelines and restrictions on collecting, using, and maintaining patient-protected healthinformation. Though it may be too early to expect any form of regulation this year regarding AI from governing bodies in lifesciences, we all know it is coming.
. “Unlocking the insights contained in patient genomic and phenotypic data is of high value to all the key stakeholders in the health care ecosystem: patients, providers, payers and the lifesciences sector,” EY introduces the report. What’s not CGD are data covered by HIPAA. The reality of U.S.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content